# Monopar Therapeutics: Form 8-K, filed Sep 24, 2025

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: 8-K
- Filed: 2025-09-24
- Accepted by EDGAR: Sep 24, 2025, 17:06 ET
- Period: 2025-09-23
- Accession: 0001437749-25-029819
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000143774925029819/mnpr20250924_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000143774925029819/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000143774925029819/mnpr20250924_8k.htm

Filed Sep 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-029819. Last ingested by Listed: Nov 4, 2026, 20:49 ET. No prices; not investment advice.